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ABSTRACT Tyrosine phosphorylation is key for signal transduction from exogenous
stimuli, including the defense against pathogens. Conversely, pathogens can subvert
protein phosphorylation to control host immune responses and facilitate inva-
sion and dissemination. The bacterial effectors EspJ and SeoC are injected into host
cells through a type III secretion system by enteropathogenic and enterohemor-
rhagic Escherichia coli (EPEC and EHEC, respectively), Citrobacter rodentium, and Sal-
monella enterica, where they inhibit Src kinase by coupled amidation and ADP-
ribosylation. C. rodentium, which is used to model EPEC and EHEC infections in
humans, is a mouse pathogen triggering colonic crypt hyperplasia (CCH) and colitis.
Enumeration of bacterial shedding and CCH conﬁrmed that EspJ affects neither tol-
erance nor resistance to infection. However, comparison of the proteomes of intesti-
nal epithelial cells isolated from mice infected with wild-type C. rodentium or
C. rodentium encoding catalytically inactive EspJ revealed that EspJ-induced ADP-
ribosylation regulates multiple nonreceptor tyrosine kinases in vivo. Investigation of
the substrate repertoire of EspJ revealed that in HeLa and A549 cells, Src and Csk
were signiﬁcantly targeted; in polarized Caco2 cells, EspJ targeted Src and Csk and
the Src family kinase (SFK) Yes1, while in differentiated Thp1 cells, EspJ modiﬁed
Csk, the SFKs Hck and Lyn, the Tec family kinases Tec and Btk, and the adapter
tyrosine kinase Syk. Furthermore, Abl (HeLa and Caco2) and Lyn (Caco2) were
enriched speciﬁcally in the EspJ-containing samples. Biochemical assays revealed
that EspJ, the only bacterial ADP-ribosyltransferase that targets mammalian ki-
nases, controls immune responses and the Src/Csk signaling axis.
IMPORTANCE Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC and
EHEC, respectively) strains cause signiﬁcant mortality and morbidity worldwide. Citro-
bacter rodentium is a mouse pathogen used to model EPEC and EHEC pathogenesis
in vivo. Diarrheal disease is triggered following injection of bacterial effectors, via a
type III secretion system (T3SS), into intestinal epithelial cells (IECs). While insights
into the role of the effectors were historically obtained from pathological, immuno-
logic, or cell culture phenotypes, subtle roles of individual effectors in vivo are often
masked. The aim of this study was to elucidate the role and speciﬁcity of the ADP-
ribosyltransferase effector EspJ. For the ﬁrst time, we show that the in vivo processes
affected by a T3SS effector can be studied by comparing the proteomes of IECs ex-
tracted from mice infected with wild-type C. rodentium or an espJ catalytic mutant.
We show that EspJ, the only bacterial ADP-ribosyltransferase that targets mammalian
kinases, regulates the host immune response in vivo.
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Protein phosphorylation has been documented on 75% of the human proteome,with the number of human phosphorylation sites estimated to be several hundred
thousand (1). The human genome encodes 58 membrane-spanning receptor tyrosine
kinases (RTKs) and 32 nonreceptor tyrosine kinases (NRTKs), which are reported to be
responsible for 1% of the total protein phosphorylation (2). Nonetheless, tyrosine
phosphorylation coordinates the response to a multitude of intracellular and extracel-
lular triggers, including growth factor signaling, cell cycle control, regulation of tran-
scription factors, and the transduction of signaling from immune cell receptors.
The NRTKs include a range of regulatory domains accompanying the core kinase
domain. The Src family kinases (SFKs) include eight NRTKs, i.e., the ubiquitous Src, Yes1,
and Fyn proteins and the classically hematopoietic Hck, Lck, Lyn, Fgr, and Blk proteins.
SFKs contain N-terminal lipidation sites for membrane tethering, followed by Src
homology 3 (SH3) and SH2 domains and an SH1 kinase fold. The SH3 and SH2 domains
provide autoregulation and substrate speciﬁcity through their respective proline-rich
region and phosphotyrosine-binding capacities (3). This SH3-SH2-SH1 core is conserved
in the C-terminal Src kinase (Csk), Abl, and Tec families (4). Csk is recruited to sites of
SFK activity, where it inhibits the SFKs through phosphorylation of their unique
C-terminal tyrosine (5). Abl kinase contains additional DNA- and actin-binding domains
and modulates the cell cycle, morphology, and motility. Tec kinases have a pleckstrin
homology domain for membrane tethering, where they signal downstream of antigenic
B- and T-cell receptors stimulating phospholipase C and calcium mobilization and
regulating actin reorganization and cell polarization (6). In Syk kinases, the SH3 domain
is replaced with a second SH2 domain enabling their recruitment to phosphorylated
immunoreceptor tyrosine activation motifs of activated B-cell, T-cell, and Fc receptors
(FcR) (7). Crucially, the Abl, Tec, and Syk kinases may each be regulated by SFKs, which
explains the plethora of overlapping roles attributed to the SFKs. Misregulation of
tyrosine kinases has been associated with many diseases, including cancer. Accordingly,
these proteins have long been attractive therapeutic targets (8). As tyrosine phosphor-
ylation is also central to the host response to infection, it is often targeted by pathogens
to evade the immune system. Moreover, the infection strategy of many viral and
bacterial pathogens involves the exploitation of host protein kinases for multiplication
and dissemination.
The enteric human pathogens enteropathogenic Escherichia coli (EPEC) and entero-
hemorrhagic E. coli (EHEC) and the mouse pathogen Citrobacter rodentium are known
as attaching and effacing (A/E) pathogens. Infection with C. rodentium causes colitis and
colonic crypt hyperplasia (CCH) (9). Colonization of the gastrointestinal tract by these
pathogens is meditated by a type III secretion system (T3SS), which injects bacterial
effector proteins into the host cell cytosol to hijack signaling for the beneﬁt of the
bacterium. Numerous T3SS effectors have an enzymatic activity, including the glyco-
syltransferase NleB, the methyltransferase NleE, and metalloproteases NleC and NleD,
which can inhibit host inﬂammatory pathways (10). A characteristic feature of infection
by A/E pathogens is the formation of actin-rich pedestals following clustering of the
effector Tir in the plasma membrane by the bacterial adhesin intimin; pedestal forma-
tion by EPEC and C. rodentium is dependent on Tir tyrosine phosphorylation by a range
of redundant NRTKs, including members of the Abl/Arg and Src families (11).
Recently, we have shown that the effector EspJ is an ADP-ribosyltransferase (ART)
that inhibits complement receptor 3 (CR3)- and FcR-mediated phagocytosis via the
inhibitory ADP-ribosylation of Src (12). Moreover, we have shown that the EspJ homo-
logues SeoC and SboC, expressed by Salmonella enterica subsp. salamae and arizonae
and S. bongori, respectively, also ADP-ribosylate the highly conserved Src glutamic acid
residue at position 310 (E310) to inhibit phagocytosis (13). EspJ is a novel ART, as it
simultaneously amidates and ADP-ribosylates Src E310, resulting in an ADP-ribose-
conjugated glutamine. This study aimed to determine the repertoire of EspJ substrates
and its role during in vivo infection.
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RESULTS
EspJ regulates the host immune response in vivo. Previous studies of EspJ were
performed mainly by infecting cultured cells for a few hours (12, 13). However, in vivo,
A/E pathogens primarily interact with intestinal epithelial cells (IECs) over several days
or weeks. Indeed, by quantifying proteomic responses of IECs isolated from mice 8 days
postinfection with wild-type (WT) C. rodentium, we have recently shown that it affects
cellular bioenergetics and cholesterol homeostasis (14).
We ﬁrst analyzed the infection dynamics after oral gavage of mice with WT or ΔespJ
or ΔART (ΔespJmutant complemented on the genome with espJR79A catalytic mutation)
mutant C. rodentium. Each strain showed similar colonization dynamics (Fig. 1a) and
induced comparable levels of CCH (Fig. 1b to e), as measured by colonic crypt length
and Ki-67 staining (a marker for cell proliferation). To investigate the role of EspJ in vivo,
FIG 1 C. rodentium ΔART colonizes mice and induces CCH. C57BL/6 mice were inoculated with WT C. rodentium, C. rodentium ΔespJ, an
EspJ catalytic mutant (ΔART), or PBS. CFU, colony forming units. (a) Colonization was assessed by determining the number of CFU per gram
of stool sample at days 3, 6, 7, and 8 postinfection. ΔARTmutant (red), ΔespJmutant (blue), and WT (black) C. rodentium were shed equally.
Crypt lengths (b) and proliferation (Ki-67 staining) (c) were measured to assess CCH in H&E-stained sections of the distal colon from PBS-
or C. rodentium (WT, ΔespJ, or ΔART)-injected mice. The ΔART mutant and WT strains signiﬁcantly induced lengthening of the crypts to
similar levels. UI, uninfected. (d, e) Representative H&E-stained and immunoﬂuorescence section images (4’,6-diamidino-2-phenylindole
[DAPI], blue; Ki-67, red; C. rodentium, green). Statistical signiﬁcance was determined by one-way analysis of variance, followed by
Bonferroni’s post-test. *, P  0.05. Red line, mean crypt length. Bars in panels d and e, 200 m.
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we then performed proteomics analysis of IECs puriﬁed from mice at the peak of
shedding, 8 days postchallenge with WT or ΔARTmutant C. rodentium. We used isobaric
peptide labeling (tandem mass tag [TMT]) and MS3 quantiﬁcation, as recently reported
(14), to determine protein abundance changes in IECs isolated frommock-infected mice
or mice infected with WT or ΔART C. rodentium (four, ﬁve, and six mice per group,
respectively).
We identiﬁed 7,400 mouse proteins and quantiﬁed them by shotgun proteomics
analysis of isobarically labeled IEC proteins (false-discovery rate [FDR]-corrected P value,
0.01). Compared to the protein abundances in uninfected IECs, those of 3,393 protein
abundances were changed by 1.5-fold upon WT infection and those of 3,164 were
changed upon ΔART mutant infection, with 2,650 of these changes observed in both
infections (see Fig. S1a in the supplemental material). We performed KEGG pathway
gene ontology (GO) term analysis of the proteins with 1.5-fold abundance changes
upon WT or ΔART infection. The pathways regulated by WT and ΔART infections were
very similar and reﬂected observations in our previous report (14) (Fig. S1b and c). In
comparison to WT infection, 457 proteins were increased 1.5-fold in the absence of
active EspJ (ΔART infection), suggesting that these proteins are induced during WT
infection but directly or indirectly suppressed by EspJ catalysis (Fig. 2a; Table S3).
ClueGO biological process analysis of these 457 proteins suggests that EspJ has
immunoregulatory roles, modulating proteins linked to the defense response to other
organisms, regulation of immune cell migration and adhesion, cytokine responses,
phagocytosis, and manipulation of the actin cytoskeleton (Fig. 2b). ClueGO cell com-
ponent analysis revealed that these proteins are localized in and around the cell
periphery; vesicles/phagosome, membrane, cytoskeleton/cortex, cell adhesions,
and extracellular matrix (Fig. 2c). This is consistent with the fact that Src, the known EspJ
target, is membrane tethered and has signiﬁcant roles in the innate immune response
and the actin cytoskeleton (15). However, considering that EspJ ADP-ribosylates a
universally conserved kinase domain residue (Src E310) (12) and its broad effect during
infection (Fig. 2), we hypothesized that its catalytic activity may impact multiple kinases.
EspJ regulates numerous tyrosine kinases in vivo. We used the kinase enrich-
ment analysis (KEA) function within the Expression2Kinases (X2K) software to predict
upstream regulatory kinases from the group of 457 proteins repressed by EspJ (16). KEA
draws from kinase perturbation studies within numerous protein and gene expression
databases to enable the prediction of upstream regulatory kinases responsible for
changes in protein abundances. Twelve of the 15 most probable kinases regulated by
EspJ were tyrosine kinases; 10 of these are NRTKs (Fig. 2d), of which 7 were present in
the IEC proteome. Importantly, none of these kinases were signiﬁcantly predicted from
10 randomly generated sets of 457 proteins (Fig. 2d; Table S4). When ΔART mutant-
infected and WT-infected IECs were compared, the abundance of Hck increased by
2-fold, but it was the only kinase from this group to change by 1.5-fold (Table 1).
In conclusion, the in vivo proteomics data are consistent with the hypothesis that EspJ
regulates multiple tyrosine kinases, including members of the Src, Fak, Jak, and Syk
NRTK subfamilies (Fig. 2d; Table S4).
EspJ can ADP-ribosylate a suite of NRTKs. To test the hypothesis that EspJ
regulates the activity of multiple kinases, we investigated its substrate repertoire in
numerous cell lysates. Recombinant EspJEHEC and 2-ethynyl-adenosine-NAD (eNAD)
were incubated with cell lysates before the conjugation of biotin onto resulting
ADP-ribosylated proteins (17) and their enrichment with NeutrAvidin resin. Proteins
were quantiﬁed by label-free quantitation (LFQ) mass spectrometry (MS) (PRIDE project
PXD008533). Proteins enriched by the presence of EspJ were identiﬁed by using a
two-sided t test and with an FDR-corrected P value of 0.01 and a fudge factor (s0)
value of 1.
In HeLa (human cervical epithelial) and A549 (human alveolar epithelial) cell lysates,
Src and Csk were signiﬁcantly enriched (Fig. 3a and b). In polarized Caco2 (human
epithelial colorectal) cell lysate, Src and Csk were again enriched, along with the SFK
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Yes1 (Fig. 3c). In differentiated Thp1 cells (human monocytes), lysate EspJ modiﬁed the
largest range of targets, i.e., Csk, the SFKs Hck and Lyn, the Tec family kinases Tec and
Btk, and the adapter tyrosine kinase Syk. Failure to enrich any of these kinases after
incubation with the inactive maltose binding protein (MBP)-EspJD187A showed that
their modiﬁcation depends upon a functional EspJ ART domain (Fig. 4). Closer analysis
reveals that Abl (HeLa and Caco2 lysates) and Lyn (Caco2 lysate) are enriched speciﬁ-
cally in the EspJ-containing samples but below the signiﬁcance cut-off after imputation
for missing values (Fig. S2 and Table S5). This shows that EspJ can ADP-ribosylate a
range of NRTKs from multiple cell lineages but suggests speciﬁcity within the tyrosine
FIG 2 EspJ is an immunosuppressant that regulates multiple tyrosine kinases in vivo. Proteomes of IECs puriﬁed from mice inoculated with WT
C. rodentium, a C. rodentium EspJ catalytic mutant (ΔART), or PBS (uninfected [UI]). (a) A ratio of ΔART mutant to WT protein abundances was
created and ranked according to those that increased the most in ΔART mutant- versus WT-infected IECs (left). The enlarged image shows 457
proteins with abundance increases of at least 1.5-fold in ΔART mutant compared to WT infections; which were assigned to 10 GO term groups
for biological process (b) and cellular components (c). Analyses are shown with the number of GO term-associated proteins in grey bars and the
negative log P value (with Bonferroni correction) indicated by black crosses. Abbreviations: () Reg., negative regulation; Inorg./ox. response,
response to inorganic substance/oxidative stress; Exc., extracellular; FA, focal adhesion. (d) The 15 most likely upstream regulatory kinases targeted
by EspJ to produce the observed changes in protein abundance. Grey bars show the kinase P value for the group of EspJ-modulated proteins,
and black bars show the mean P value of the kinase across X2K runs from 10 random lists of 457 proteins from the total of 7,400. Check marks
(✓) highlight the tyrosine kinases within this prediction and whether the kinase was identiﬁed in the IEC proteome. See also Fig. S1 and S2.
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kinases due to the absence of other key NRTKs. Further, despite the proteomic
identiﬁcation of RTKs and serine/threonine kinases in these cell lines, none were
conﬁdently enriched (Table S5). The SH2 domain is common to the Src, Tec, Syk, and
Csk subfamilies but is not found in the FAK and JAK subfamilies. To test whether SH2
plays a role in kinase recognition, green ﬂuorescent protein (GFP)-tagged SrcWT and
SH2 domain R175K mutant Src unable to bind phosphotyrosines (SrcRK) (18) were
immunoprecipitated from HeLa cells before incubation with MBP-EspJEHEC and NAD-
biotin. EspJ was able to ADP-ribosylate the Src SH2 domain mutant at an efﬁciency
similar to that of WT Src, suggesting that EspJ may select its targets via alternative
mechanisms (Fig. 5a and c).
EspJ shows speciﬁcity within its NRTK targets. The proteomics assay highlighted
ubiquitous SFKs Src and Yes1, but not Fyn, as EspJ targets. To test this speciﬁcity, we
assayed the ADP-ribosylation of a panel of immunoprecipitated, GFP-tagged kinases
incubated with EspJ and NAD-biotin as described above. EspJ could ADP-ribosylate all
of the kinases tested (Src, Yes1, Fyn, Csk, and Abl) (Fig. 5b). Semiquantitative densi-
tometry was used to infer the ADP-ribosylation efﬁciency from the ratio of ADP-
ribosylated protein (anti-biotin antibody Western blot assay) to total protein (anti-GFP
TABLE 1 Kinases identiﬁed in IEC proteomesa
aShown are the kinases identiﬁed in the proteomes of uninfected IECs and IECs infected with WT or ΔART mutant C. rodentium, their respective
log2 abundances, and the fold differences between ΔART mutant and WT infection conditions. In addition, whether they were predicted to be
regulated by EspJ in vivo by KEA or ADP-ribosylated by EspJ in cell lysate is noted. Protein log2 abundances range from blue (low) to white
(medium) to red (high). UI, uninfected.
Pollard et al. ®
March/April 2018 Volume 9 Issue 2 e00170-18 mbio.asm.org 6
 o
n
 Septem
ber 6, 2018 by guest
http://m
bio.asm
.org/
D
ow
nloaded from
 
FIG 3 In vitro chemical proteomics analysis suggests that EspJ can ADP-ribosylate multiple tyrosine kinases. Lysates from HeLa (a), A549 (b),
polarized Caco2 (c), and differentiated Thp1 (d) cells were incubated with EspJEHEC and eNAD. ADP-ribosylated proteins were tagged with biotin
by click chemistry before enrichment with NeutrAvidin resin and analysis by LFQ MS. Red dots represent proteins that were signiﬁcantly enriched
when abundances in the presence versus the absence of EspJ were compared. Data sets were subjected to a two-sided t test, and black lines
display the signiﬁcance cutoff with an FDR-corrected P value of 0.01 and an s0 value of 1. See also Fig. S2.
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antibody Western blot assay) across three to ﬁve experiments. This suggested that the
SFK Fyn was modiﬁed at less than half the efﬁciency of its family members Src and Yes1
and the non-SFK Abl kinase (Fig. 5C). Interestingly, while Csk was the only kinase to be
ADP-ribosylated by EspJ in all four cell lysates (Fig. 3), it was the weakest GFP-tagged
substrate in this assay (Fig. 5b and c).
EspJ inhibits Csk by ADP-ribosylation. As EspJ can target both the SFKs and their
inhibitor Csk, we further investigated the EspJ-Csk relationship to understand the
interplay among EspJ, SFKs, and Csk. First, as we have previously shown that the EspJ
homologues SeoC and SboC can ADP-ribosylate Src, we conﬁrmed their ability to
ADP-ribosylate Csk (Fig. 6a). Moreover, while the catalytic mutant (D187A) EspJEHEC
protein was unable to ADP-ribosylate Csk by using biotin-NAD, WT EspJEHEC modiﬁed
Csk in a time-dependent manner (Fig. 6b). Finally, mutation of Csk E236, which is
FIG 4 EspJ ADP-ribosylation of NRTKs is dependent on a functional ΔART domain. Lysate from differentiated Thp1 cells was incubated
with EspJEHEC (WT or D187A mutant) and eNAD. ADP-ribosylated proteins were tagged with biotin by click chemistry before enrichment
with NeutrAvidin resin and analysis by LFQ MS. (A) Volcano plot after two-sided t test with a signiﬁcance cutoff of an FDR-corrected P value
of 0.01 and an s0 value of 1. (B) Proﬁle plot of individual sample LFQ intensities. Blue, Csk; black, Hck; orange, Lyn; light blue, Btk;
magenta, Tec; green, Syk.
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analogous to Src E310, prevented ADP-ribosylation, indicating that EspJEHEC targets the
same residue in Src and Csk (Fig. 6c).
As the differential effect of Csk activation or inhibition could have drastic impacts on
the regulation of Src kinase, we next tested the effect of Csk ADP-ribosylation by EspJ.
ADP-ribosylation of Csk with native NAD was performed for 2 h prior to the addition of
kinase buffer and either the synthetic tyrosine kinase substrate poly(Glu4, Tyr) or
SrcSH1-K295M/Y416A/E310A (K295M, catalytic mutant; Y416A, nonautophosphorylated;
E310A, cannot be ADP-ribosylated by EspJ). Phosphotyrosine Western blotting revealed
that while Csk could still phosphorylate Src/poly(Glu4, Tyr) after incubation with NAD
and D187A mutant EspJEHEC or TssF1 (an uncharacterized Pseudomonas aeruginosa
protein used as an additional control), WT EspJEHEC completely abolished Csk kinase
activity (Fig. 6d and e). This conﬁrms that EspJ can ADP-ribosylate and inhibit both the
SFKs and their inhibitor Csk.
DISCUSSION
Studying the role of T3SS effectors in vivo conventionally relies on the elucidation of
pathological, immunologic, or cellular phenotypes. However, as the contributions of
FIG 5 EspJ ADP-ribosylation of NRTKs displays speciﬁcity. HeLa cells were transfected with GFP, GFP-tagged Src,
or SrcR175K (SrcRK, SH2 domain mutant) (a) and Src, Yes1, Fyn, Csk, and Abl (b). The immunoprecipitated NRTKs were
incubated with MBP-EspJEHEC and NAD-biotin. ADP-ribosylated proteins were detected by Western blotting and
anti-biotin reagents. (c) The ratio of band intensities for ADP-ribosylated (biotin) to total (GFP) ﬂuorescence was
assessed by densitometry, and the mean ratio of three to ﬁve repeats is displayed for each transfected protein. EspJ
has a preference for Src, Yes1, and Abl over Fyn and Csk, and the Src SH2 domain mutant (RK) has no impact on
ADP-ribosylation by EspJ. The values to the left of the gels are molecular sizes in kilodaltons.
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FIG 6 EspJ regulates Csk via inhibitory ADP-ribosylation of E236. MBP-EspJ homologues and catalytic mutants were incubated with
His-Csk (WT and mutants) and NAD-biotin and ADP-ribosylated Csk were detected by Western blotting and anti-biotin reagent. (a) WT but
not D187A catalytic mutant MBP-EspJEHEC ADP-ribosylates Csk in a time-dependent manner. (b) EspJ homologues are able to ADP-
ribosylate Csk. (c) The E236Q mutation of Csk prevents ADP-ribosylation by EspJ. (d, e) Csk was incubated with MBP-EspJWT, catalytic
mutant MBP-EspJD187A, or the control MBP-TssF1 and NAD for 2 h before GST-Src250–533 K295M/Y416A/E310A (d) or poly(Glu4, Tyr) (e) substrate
(Continued on next page)
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many individual effectors to disease are subtle, their roles during in vivo infection
remain largely unknown. This holds true for EspJ, as an espJ mutant colonizes mice as
efﬁciently as the parental WT strain. In this paper, we show, for the ﬁrst time, that
comparing the proteomes of IECs extracted from mice infected with WT and espJ
mutant C. rodentium reveals the in vivo processes affected by EspJ. By applying this
approach to other effector mutants, we should be able to illuminate the processes they
affect at a molecular level, which will shed new light on pathogen-host interactions.
In this study, we show that EspJ can modify a range of kinases and this is suggested
to regulate the host immune response in vivo. Previously, Src kinase was the only
known substrate for EspJ. Here we show that kinases from the Src, Abl, Csk, Tec, and Syk
NRTK families are preferentially ADP-ribosylated by EspJ. Further, while predictions
from in vivo proteomics hinted that EspJ modulates JAK and FAK, these were not
ADP-ribosylated in cell lysate. While expression levels may have contributed to these
observations, several JAKs and FAKs are ubiquitously expressed and thus were likely
available for ADP-ribosylation by EspJ. Furthermore, our data suggest that within the
ubiquitously expressed SFKs, EspJ has a preference for Src and Yes1 over Fyn. Thus, EspJ
displays an intricate speciﬁcity despite ADP-ribosylating a universally conserved cata-
lytic kinase residue, Src E310. The molecular basis of target speciﬁcity is currently not
known.
The Src, Tec, and Syk NRTK families are crucial to the host immune response to
pathogens. This includes roles in phagocytosis and inﬂammatory responses, both of
which were predicted as EspJ-regulated processes in vivo (15, 19–22). A multitude of
ﬁndings link these kinases to the transduction of signaling from Toll-like receptors (TLR),
such as the inﬂammatory response to bacterial lipopolysaccharide after detection by
TLR4 (23), and Syk has been linked to signal transduction after pathogen recognition by
IECs (21). The new EspJ substrates that we have identiﬁed were either previously
observed in IECs or present in the IEC proteome from this study. As IECs are emerging
as nonprofessional immune cells critical to the defense against pathogens (24, 25), their
inhibition is likely central to the suppression of the host immune response by EspJ
in vivo.
Our study showed that EspJ can also ADP-ribosylate Csk at the conserved catalytic
glutamic acid, ablating its kinase activity. The EspJ homologues SeoC and SboC were
also able to ADP-ribosylate Csk, suggesting that the broad regulation of NRTKs may be
a conserved strategy employed by the A/E pathogens and Salmonella. As Csk is only
recruited to SFKs at the membrane upon their activation (26), by inhibiting SFKs, EspJ
could potentially prevent the recruitment of Csk. If EspJ did interact with Src and Csk
simultaneously, it has the potential to dynamically regulate both proteins, which may
be necessary for subtle control of processes such as the dynamics of the EPEC actin
pedestals. EspJ inhibition of Csk may also impact other roles for Csk, including the
regulation of G proteins or the phosphatases SHP-1 and CD45 (27–29), though further
studies are required to understand the global effect of EspJ-Csk interactions. Impor-
tantly, while Csk was found to be an EspJ target in lysates of all of the cell line tested,
it was modiﬁed with less efﬁciency than the other NRTKs following protein puriﬁcation.
Whether this reduced efﬁciency is caused by the GFP tag or represents a physiological
difference has yet to be determined.
Manipulation of tyrosine kinase signaling is rife during bacterial infections. Tyrosine
phosphorylation of EPEC Tir is mediated by Abl and SFKs. Depending on the combi-
nation of phosphorylation, either Nck or the phosphatases SHP-1 and -2 may be
recruited, stimulating downstream pedestal formation (30, 31) or inhibiting the pro-
duction of proinﬂammatory cytokines, respectively (32). Phosphorylation of Helicobac-
ter pylori CagA by Src and Abl results in drastic cell elongation and increased motility
FIG 6 Legend (Continued)
addition during a 30-min time course. Kinase activity was assessed by Western blotting with an anti-phosphotyrosine (-pTyr) antibody.
While Csk was able to phosphorylate Src and poly(Glu4, Tyr) after preincubation with EspJD187A or MBP-TssF1, ADP-ribosylation by
MBP-EspJWT fully inhibited Csk catalytic activity. The values to the left of the gels are molecular sizes in kilodaltons.
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(33). Shigella recruits Src and Abl to induce the cytoskeletal dynamics necessary for
invasion (34), and Btk is required for Shigella ﬂexneri actin tail formation and motility
(35). Contrastingly, bacteria may use phosphatases to inhibit NRTKs. Salmonella SptP is
able to dephosphorylate Syk, (36), and Yersinia YopH can dephosphorylate multiple
proteins, including NRTKs and targets thereof, controlling internalization, integrins, and
immunoreceptor signaling (37).
While EspJ is the only bacterial ART that targets mammalian kinases, other T3SS
ARTs can suppress the host immune response, such as HopF2 from the plant pathogen
Pseudomonas syringae, which ADP-ribosylates mitogen-activated protein kinase ki-
nases. The Pseudomonas aeruginosa ARTs ExoS and ExoT can inhibit phagocytosis by
ADP-ribosylation of a distinct set of host proteins despite sharing 76% sequence
identity (38). The EspJ homologues show sequence identity as low as 57% (13).
Accordingly, these ARTs may have broader target repertoires, though deeper proteom-
ics analysis is required to fully elucidate their speciﬁcity and downstream functions.
MATERIALS AND METHODS
Animals. Animal experiments were performed in accordance with the Animals Scientiﬁc Procedures
Act 1986 and approved by the local Ethical Review Committee and UK Home Ofﬁce guidelines.
Experiments were designed in agreement with the ARRIVE guidelines (39) for the reporting and
execution of animal experiments, including sample randomization and blinding. Pathogen-free female
C57BL/6 mice (18 to 20 g, six per group; Charles River, Inc., United Kingdom) were housed in HEPA-
ﬁltered cages with sterile bedding (processed corncobs grade 6) and nesting (LBS Serving Technology)
and free access to sterilized food (LBS Serving Technology) and water.
DNA manipulation: plasmid construction and site-directed mutagenesis. pCB6-GFP plasmids
containing Src (WT and R175K mutant), Yes1, Fyn, and Abl were kindly provided by Michael Way (Francis
Crick Institute, London). Csk was subcloned into pCB6 and pET28 by restriction enzyme digestion,
ligation, and transformation. Site-directed mutagenesis for EspJ D187A and Csk E236Q was performed by
nonoverlapping inverse PCR, followed by product phosphorylation and ligation with T4 DNA ligase. For
the primers and restriction enzymes used, see Table S1, and for the plasmids used, see Table S2. All
enzymes were from NEB.
Generation of C. rodentium espJ and R79A (ART) mutants. The EspJ ﬂanking regions were
ampliﬁed by PCR with primers 9/10 and 11/12 before digestion alongside the pSEVA612S vector
(Table S1). Vectors were assembled by triple ligation before transformation into E. coli CC118pir (40).
Triparental conjugation, followed by gene excision with arabinose-inducible I-SceI, was utilized to
delete espJ from C. rodentium as previously described (14). Clones were screened by PCR for espJ deletion
with primers 15/16 before PCR product sequencing (Table S1). The same methodology was used to
reintegrate espJ-R79A into the genome with pSEVA612S-()300bp-EspJR79A-()300bp generated by
site-directed mutagenesis (primers 13/14).
Eukaryotic cell maintenance. HeLa, A549, Caco2, and Thp1 cells were maintained at 37°C and 5%
CO2 (Table 2). For polarization, Caco2 cells were seeded into six-well plates at 1  105/well and the
medium was exchanged at days 2, 4, 6, and 7 to 14. For differentiation, Thp1 cells were seeded at 2 
107/10-cm dish in the presence of 0.02% phorbol 12-myristate 13-acetate (PMA). Forty-eight hours later,
the medium was changed to medium lacking fetal calf serum (FCS) and PMA.
IP. HeLa cells were seeded into six-well plates at 1.5  105/well and transfected 24 h later with 2.5
g of plasmid DNA and 5 l of Lipofectamine 2000 (Thermo Fisher Scientiﬁc) per well. Fourteen hour
later, cells were washed twice with phosphate-buffered saline (PBS) and lysed with kinase immunopre-
cipitation (IP) buffer on ice before sonication. Lysates were clariﬁed at a relative centrifugal force (RCF)
of 20,000 for 10 min and precleared for 15 min with Dynabeads protein G (Thermo Fisher Scientiﬁc).
Incubations were performed at 4°C with rotation. Supernatants were incubated with rabbit anti-GFP
antibody 9F9.F9 (Abcam, Inc.)-conjugated Dynabeads for 1 h. Beads were sequentially washed with
PBS–0.5% Triton X-100, PBS–0.05% Tween 20, 150 mM NaCl–20 mM Tris (pH 8), and kinase IP buffer
before ADP-ribosylation by recombinant MBP-EspHEHEC.
In vitro enzyme reactions. Four micrograms of Csk was added to 4 g of puriﬁed MBP-EspJEHEC or
to EspJ homologues bound to 50 l of amylose resin. Immunoprecipitated tyrosine kinases were
incubated with 2 g of puriﬁed MBP-EspJEHEC. The above ADP-ribosylation reactions with 6-biotin-17-
NAD (NAD-biotin; AMSBIO) were performed for 1 h at room temperature in ADP-ribosylation buffer
(Table 3) and terminated with Laemmli buffer and boiling.
For testing of Csk inhibition, 1 mM MBP-EspJWT, -EspJD187A, or -TssF1 was incubated with 10 M
His-Csk in ADP-ribosylation buffer. After 2 h, glutathione S-transferase (GST)-Src250–533 K295M/Y416A/E310A or
poly(Glu4, Tyr) (Sigma) was added to 1 mM with 10 kinase reaction buffer and the mixture was
incubated for 1, 5, 15, or 30 min.
For proteomics screening of EspJ targets, 400 g of HeLa, A549, Caco2, or Thp1 cell lysate in
ADP-ribosylation buffer was incubated with 20 g of MBP-EspJEHEC and eNAD (Jena Biosciences CLK-043)
for 3 h at room temperature.
Click chemistry and pulldown of ADP-ribosylated proteins for LFQ liquid chromatography
(LC)-MS. Cell lysate reaction products were chloroform-methanol precipitated with 4 volumes of
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methanol, 1.5 volumes of chloroform, and 2 volumes of water before being washed twice with ice-cold
methanol and resuspended in 25 l of 2% SDS–PBS by vortex mixing for 30 min and dilution to 0.5%
SDS–PBS with PBS. Biotin was conjugated to proteins by using reaction mixtures containing 100 M AzRB
(azide [Az], arginine [R], and biotin [B]; structure 3 in Fig. 1 of reference 17), 1 mM CuSO4, 1 mM
tris(2-carboxymethylphosphine) (TCEP), and 100 M tris(1-benzyl-1H-1,2,3-triazol-4-yl)methylamine
(TBTA) for 2 h. Reactions were quenched by chloroform-methanol precipitation, and reaction products
were resuspended in 50 l of 2% SDS–PBS as described above.
Samples were diluted with PBS to 0.2% SDS–PBS and incubated with 30 l of slurry or prewashed
NeutrAvidin resin (Thermo Fisher Scientiﬁc) per sample for 1 h. Resin was washed three times with 1%
TABLE 2 Reagents and resources used in this studya
Reagent or resource Source or reference Identiﬁer
Bacterial strains
C. rodentium
WT Frankel lab 1CC169
ΔART (espJ R79A) mutant Frankel lab ICC1472
E. coli
CC118pir 39 NAc
CC1047 40 NA
Antibodies
GST, mouse monoclonal 3G10/1B3 Abcam, Inc. Catalog no. ab92, RRIDd AB_307067
MBP, mouse monoclonal MBP-17 (HRP)b Abcam, Inc. Catalog no. ab49923, RRID AB_881602
His, mouse monoclonal (HRP) Sigma-Aldrich Catalog no. A7058, RRID AB_258326
Phosphotyrosine, mouse monoclonal PY20 Sigma-Aldrich Catalog no. P4110, RRID AB_477342
Csk, rabbit monoclonal C74C1 Cell signaling technology Catalog no. 4980S, RRID AB_2276592
GFP, mouse monoclonal 9F9.F9 Abcam, Inc. Catalog no. ab1218, RRID AB_298911
GFP, rabbit monoclonal Abcam, Inc. Catalog no. ab290, RRID AB_303395
Peroxidase-AfﬁniPure goat anti-mouse IgG, Fc gamma fragment
speciﬁc
Jackson ImmunoResearch, Inc. Catalog no. 115-035-008, RRID AB_2313585
Peroxidase-AfﬁniPure goat anti-rabbit IgG, Fc fragment speciﬁc Jackson ImmunoResearch, Inc. Catalog no. 111-035-008, RRID AB_2337937
Intimin B puriﬁed chicken antibody IgY John Morris Fairbrother; 41 NA
Ki-67 rabbit monoclonal antibody (clone SP6) Thermo Fisher Scientiﬁc Catalog no. RM-9106-F0; RRID AB_721371
Cy3 AfﬁniPure goat anti-chicken IgY (IgG) (HL) J Jackson ImmunoResearch Catalog no. 103-005-155; RRID AB_2337379
Alexa Fluor 488 AfﬁniPure donkey anti-rabbit IgG (HL) Jackson ImmunoResearch Catalog no. 711-545-152; RRID AB_2313584
Chemicals and reagents
eNAD Jena Bioscience Catalog no. CLK 043
Lipofectamine 2000 transfection reagent Invitrogen Catalog no. 12566014
AzRB 17 NA
DAPI Thermo Fisher Scientiﬁc Catalog no. D3571, RRID AB_2307445
Pathogen-free female C57BL/6 mice Charles River, Inc. (United
Kingdom)
Strain code 027
aShown are the key strains, antibodies, chemicals, and animals used in this study, accompanied by their sources and identiﬁers.
bHRP, horseradish peroxidase.
cNA, not applicable.
dRRID, research resource identiﬁer.
TABLE 3 Composition of the buffers and cell culture media used in this study
Buffer or medium Composition
Kinase IP 20 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate,
1 mM -glycerophosphate, 1 mM Na3VO4, 1 mM dithiothreitol (DTT), 0.5% NP-40, 2 cOmplete mini
EDTA-free protease inhibitor tablets (Roche), 5 l of Benzonase nuclease/10 ml
MBP lysis/gel ﬁltration 500 mM NaCl, 50 mM CAPS,a 5 mM DTT, 10% glycerol (pH 10)
GST lysis/gel ﬁltration 300 mM NaCl, 50 mM Na2HPO4, 5 mM DTT, 5% glycerol (pH 7.4)
His lysis/gel ﬁltration 50 mM Tris (pH 8), 150 mM NaCl, 10% glycerol, 2 mM DTT
ADP-ribosylation 50 mM Tris (pH 7.4), 1 mM DTT, 60 M ATP, 5 mM MgCl2
1 Kinase buffer 100 mM KCl, 100 mM MOPS,b 10 mM DTT, 10 mM MgCl2, 100 M ATP
Enterocyte dissociation buffer 1 Hanks’ balanced salt solution without Mg and Ca plus 10 mM HEPES, 1 mM EDTA, and 5 l/ml
2--mercaptoethanol
HeLa, A549, or Caco2 cell
maintenance
Dulbecco’s modiﬁed Eagle’s medium (Sigma-Aldrich) containing 1,000, 1,000, or 4,500 mg/liter glucose,
1% (vol/vol) GlutaMAX (Life Technologies, Inc.), and 10% (HeLa, A549) or 15% heat-inactivated FCS
Thp1 cell maintenance RPMI supplemented with 10% FCS
aCAPS, N-cyclohexyl-3-aminopropanesulfonic acid.
bMOPS, morpholinepropanesulfonic acid.
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SDS–PBS, twice with 4 M urea–PBS, and three times with 50 mM ammonium bicarbonate–H2O (pH 8)
before digestion with 0.4 g of trypsin in 50 l of 50 mM ammonium bicarbonate (pH 8) overnight at
37°C with vortex mixing.
Digested peptide supernatants were combined with supernatants from subsequent washes with
80 l of 50 mM ammonium bicarbonate and 80 l of 0.1% triﬂuoroacetic acid (TFA). Peptides were
loaded onto methanol-activated and pre-equilibrated home-made StageTips consisting of three layers of
SDB-XC (Empore) solid-phase extraction medium, desalted with H2O, and eluted with 79% acetonitrile
(ACN) before being vacuum dried and stored at 80°C. For analysis, samples were resuspended in 15 l
of 0.5% TFA–2% ACN and transferred to LC-MS vials.
LFQ MS—in vitro ADP-ribosylation. (i) MS. For a detailed description of MS and data processing,
see Text S1 in the supplemental material. Analysis was performed with an EASY-Spray LC column coupled
to a Q Exactive mass spectrometer via an EASY-Spray Source (Thermo Fischer Scientiﬁc) in a data-
dependent acquisition mode (data were processed using MaxQuant version 1.5.7.4).
(ii) Volcano plot generation. Protein groups were analyzed with Perseus (version 1.5.6.0). Potential
contaminants, “reverse,” “identiﬁed by site,” and proteins with only one unique peptide were removed
and data were logarithmized (log2). Replicates were grouped and ﬁltered for proteins with at least three
valid values across three (Caco2, THP-1) or four (A549, HeLa) replicates in one group. Missing values were
imputed with a downshifted normal distribution (1.8 downshift, 0.3 width) for each sample to allow
statistical analysis by a two-sided t test within the volcano plot function (permutation-based FDR-
corrected P value of 0.01, s0 value of 1) (Table S5).
Infection of mice with C. rodentium. Oral gavage was used to inoculate mice with 200 l of PBS
(uninfected) or C. rodentium (ca. 5  109 CFU). The inoculum was determined by counting CFU after
plating on LB agar supplemented with nalidixic acid, and colonization was monitored by counting CFU
per gram of stool sample on days 3, 6, 7, and 8.
Tissue staining and measurement. A 0.5-cm section of the distal colon was washed with PBS, ﬁxed
in 1 ml of buffered formalin, parafﬁn embedded, and sectioned at 5 m. Sections were stained with
hematoxylin and eosin (H&E) or treated with sodium citrate antigen demasking solution prior to
immunoﬂuorescence staining (antibodies, Table 2). CCH was assessed by measuring at least 20 crypt
lengths in samples from at least four mice per group.
Enterocyte extraction. Eight days postinfection, a 4-cm section of the terminal colon was cut
lengthwise and incubated for 45 min at 37°C in 4 ml of enterocyte dissociation buffer. Enterocytes were
harvested by centrifugation at an RCF of 2,000, washed twice in PBS, and stored at 80°C prior to
labeling.
Digestion and TMT labeling. Enterocytes were dissolved in 100 l of 0.1 M triethylammonium
bicarbonate (TEAB)–0.1% SDS and lysed by pulse probe sonication. Eighty micrograms of protein per
sample was SpeedVac dried and then resuspended in 100 l of 4% SDS–100 mM TEAB–15 mM TCEP,
assisted with an ultrasonic bath. After reduction at 56°C for 20 min, samples were cooled to 25°C and
alkylated with iodoacetamide (IAA) for 30 min. Proteins were puriﬁed by 20% trichloroacetic acid
precipitation, followed by one wash with ice-cold acetone before resuspension in 100 mM TEAB and
digestion with 3 g of trypsin (MS grade; Pierce) at 37°C for 18 h. Forty micrograms of protein digest
was labeled with 0.4 mg of TMT10plex as instructed by the manufacturer (Thermo Fisher Scientiﬁc).
IEC proteome MS. (i) MS. For a detailed description of MS and data processing, see Text S1 in the
supplemental material. Brieﬂy, samples were fractionated with a U3000 high-performance liquid chro-
matography system (Thermo Fisher Scientiﬁc) coupled to an XBridge ethylene-bridged hybrid C18
column (Waters). Peptides were injected onto the Orbitrap Fusion Tribrid mass spectrometer coupled to
a U3000 RSLCnano ultrahigh-performance liquid chromatography system (Thermo Fisher Scientiﬁc)
loading onto a PepMap C18 trap and separated on a PepMap C18 column. Data acquisition was done by
the SPS10-MS3 method.
(ii) Bioinformatics analysis. Protein groups were processed with Perseus (version 1.5.6.0). Absolute
intensities were logarithmized (log2), and those with only one unique peptide were removed. Ratios
between conditions were created, and proteins with a fold change of 1.5 were analyzed further. Venn
diagrams were created in BioVenn (41), and heat maps were created in Perseus.
GO terms were analyzed with the ClueGO Cytoscape plug-in (version 3.6.0) (42, 43). The minimum
and maximum GO levels were set to 3 and 7, respectively. GO terms with a P value of 0.01 were
selected with a minimum of ﬁve proteins and 5% of the GO term proteins. GO term grouping and fusion
were utilized, and the most signiﬁcant (Bonferroni-corrected P value) GO term was used for visual
representation.
The kinase prediction function (KEA) of X2K (16) was used in isolation to predict upstream regulatory
kinases from the group of 457 proteins upregulated in the ΔART versus WT samples or from 10 randomly
generated sets of 457 proteins from the total of 7,400 proteins identiﬁed.
Availability of data. The data sets obtained in this study can be found in PRIDE project PXD008533.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
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